WO2001062976A1 - Rapid nucleic acid separation, isolation and purification methods - Google Patents

Rapid nucleic acid separation, isolation and purification methods Download PDF

Info

Publication number
WO2001062976A1
WO2001062976A1 PCT/US2001/005575 US0105575W WO0162976A1 WO 2001062976 A1 WO2001062976 A1 WO 2001062976A1 US 0105575 W US0105575 W US 0105575W WO 0162976 A1 WO0162976 A1 WO 0162976A1
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
solid surface
dyn
water
surface tension
Prior art date
Application number
PCT/US2001/005575
Other languages
French (fr)
Inventor
Wen Shao
Original Assignee
Wen Shao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wen Shao filed Critical Wen Shao
Priority to AU2001238616A priority Critical patent/AU2001238616A1/en
Publication of WO2001062976A1 publication Critical patent/WO2001062976A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Abstract

Provided are rapid and simple methods for isolation and purification of nucleic acid from crude samples.

Description

Rapid Nucleic Acid Separation, Isolation and Purification Methods
BACKGROUND OF THE INVENTION
I. Field of the Invention
The present invention relates to the isolation and purification of nucleic acids.
II. Background
Methods for nucleic acid isolation and purification have existed and been known for years. For example, ionic exchange resins have been used for purification of nucleic acid since 1950's (W.E. Cohn, Ann. N.Y. Acad. Sci., 57, p204, 1953). Nucleic acids, proteins and other impurities are attached onto solid support through anion exchange. Through washings, proteins and unwanted nucleic acids are removed. Nucleic acid is eluted in high salt (i.e. 7M urea or 1.2 M NaCl) (Henco, et al., US patent 5,057,426) and, then, further purified through ethanol precipitation. Gebeyehu, et al. eluted nucleic acid with 0.5 N NaOH (US patent 4,921 ,805) which denatures nucleic acid.
Ultracentrifugation with sucrose or cesium chloride density gradients is another method of separation of nucleic acid. (Alberts, et al, Molecular biology of the Cell, pi 62, third edition, Garland Publishing, 1994) The nucleic acids are separated from other macromolecules according to their sedimentation coefficient. The sample is centrifuged at very high speed for 20 hours or longer. Phenol or chloroform/phenol extraction and ethanol or isopropanol precipitations of nucleic acids are common lab procedures. (Short Protocols in Molecular Biology, p55, John Wiley & Sons, 1989). Phenol or chloroform/phenol extractions can result in contact with these toxic organic solvents and are time-consuming procedures. Alcohol precipitation of nucleic acid from solution involve the addition of salt (e.g. 0.1 volumes of 2.5M sodium acetate (pH 5.2)) to a solution containing nucleic acids followed by addition of an alcohol (e.g. 2.5 volumes of ethanol). The nucleic acids then precipitate. The precipitated nucleic acid molecules aggregate (usually at low temperatures; e.g. 5 minutes on dry ice or 30 minutes at 4°C) and are recovered by centrifugation for 30 minutes (usually at low temperature). This is a time-consuming process, and it is more useful to concentrate prepurified nucleic acids rather than a true purification method.
More recently, affinity purification procedures have been used in nucleic acid field. Nucleic acids and impurities are bound to solid support materials such as glass and diatomous materials through affinity binding in presence of a chaotropic agent (Padhye, et al, U.S. Patent 5,808,041; Little, US patent 5,075,430; Boom, et al, US patent 5,234,809) or mixture of chaotropic agent and an organic solvent (Wiggins, US patent 5,637,687; Chomczynski, US patent 5,945,515). However, this method has difficulty in ever tight bonding and difficulty in binding small molecules and releasing long nucleic acid. Thomas, et al., (US patent 5,175,271) showed a method of DNA extraction with silica gel and amyl alcohol. Here amyl alcohol plays same role as phenol and chloroform.
Reeve (US patent: 5,665,554 and 5,681,946) discloses that magnetic beads can precipitate DNA or protein. These DNA or proteins are precipitated on the surface of magnetic beads. The magnetic beads are collected by applying magnetic field. Woodard (US patent 5,405,951 and EP 0512767) teaches addition of alcohol to DNA solution. In presence of celite diatoms or silicas, the DNA will bind to celite diatom or silica. After drying, DNA is eluted with heating at 60°C. The binding and eluting steps need to repeat at least once. Therefore, the method is cumbersome, slow, and the recover is limited.
Mullis (US patent 5,187,083 and 5,234,824) reveals that certain membranes trap high molecular weight DNA. DNA is released in a buffer containing divalent ions such as calcium ions at elevated temperature.
Gel filtration is widely used in purification of nucleic acids. (J. Brobyt and B. White, Biochemical Techniques, page 88-95, Brooks/Cole publishing, 1987) It requires either natural gravity or centrifugation. The method of natural gravity is very time consuming, while centrifugation has limited capacity that is not suitable to high throughput purification. Furthermore, the purified samples are usually diluted after purification.
With rapid development of genome sequencing and diagnostic fields, with an increasing use of nucleic acid, speed of nucleic acid sample preparation becomes an important factor. Therefore, there is a great need to develop a nucleic acid purification, isolation and purification method which is quick, effective, and can be carried out at ambient temperature. SUMMARY OF THE INVENTION
It is an object of this invention to provide methods for the convenient isolation and purification of nucleic acids from an aqueous sample.
It is a further object of the invention to provide a kit useful for isolation and purification of nucleic acids from an aqueous sample.
In accomplishing those objectives, there is provided a method of purification of a nucleic acid from a solution comprising
the mixing an aqueous sample solution comprising a nucleic acid, an organic solvent miscible in water, and a solid surface selected from the group consisting of an inorganic solid surface having a surface tension of 38-70 dyn/cm in water at 20°C and an organic solid surface having a surface tension of 30-70 dyn/cm at 20°C; collecting the solid surface on which the nucleic acid is precipitated; and eluting the nucleic acid from the solid surface at ambient temperature.
In accordance with a preferred embodiment, the solid surface is an inorganic solid surface having a surface tension of 38-70 dyn/cm in water at 20°C. In accordance with another preferred embodiment, the solid surface is an organic solid surface having a surface tension of 30-70 dyn/cm at 20°C.
In accordance with yet another embodiment, the surface tension is between 33-60 dyn/cm at 20°C and the eluted nucleic acid is RNA. In accordance to a further embodiment, the surface tension is between 38-60 dyri/cm at 20°C and the eluted nucleic acid is DNA.
In accordance with yet another embodiment, the organic solvent is an alcohol. I a preferred embodiment, the alcohol is ethanol, isopropanol, n-propanol, or butanol.
In yet another embodiment, the method comprising a further step of washing the solid support with a wash solution comprising an organic solvent miscible in water, prior to eluting the nucleic acid. In accordance with a preferrd embodiment, any step of the method is carried out at ambient temperature.
In accordance with yet another embodiment, the elution of the nucleic acid is in an aqueous liquid having a conductivity of up to lmS/cm. In accordance with a preferred embodiment, the elution liquid is water.
In accordance with the invention, a kit is provided for purification of a nucleic acid comprising a container of washing solution comprising 30%-75% organic solvent miscible in water, and a solid surface selected from the group consisting of an inorganic solid surface having a surface tension of 38-70 dyn/cm in water at 20°C and an organic solid surface having a surface tension of 30-70 dyn/cm at 20°C, wherein the kit componentόs are used in a method for purification of nucleic acids wherein the nucleic acid is first precipitated onto the solid surface and then eluted from the solid surface at ambient temperature in an aqueous liquid having a conductivity of up to 1 mS/cm .
In accordance with an embodiment, the solid surface provided with the kit is an inorganic solid surface having a surface tension of 38-70 dyn/cm in water at 20°C.
In accordance with another embodiment, the solid surface provided with the kit is an organic solid surface having a surface tension of 30-70 dyn/cm at 20°C.
In accordance with a preferred embodiment, the solid surface is borosilicate or cellulose acetate.
In accordance with a preferred embodiment, the surface tension of the solid
surface is between 33-60 dyn/cm at 20°C and the eluted nucleic acid is RNA. In accordance with a preferred embodiment, the surface tension of the solid surface is between 38-60 dyn/cm at 20°C and the eluted nucleic acid is DNA. DETAILED DESCRIPTION OF INVENTION
The invention is based on the unexpected observation that a nucleic acid in an aqueous sample solution can be purified by mixing the sample solution with a water miscible organic solvent in presence of a solid surface having a surface tension within a particular range and eluting the nucleic acid with good recovery in a primarily salt free liquid, wherein any step of the procedure can be carried at ambient temperature.
The method of purification, isolation and separation of nucleic acid from a solution sample comprises mixing an aqueous sample solution, organic solvent miscible in water, and an inorganic solid surface having surface tension of 38-70 dyn/cm in water at 20°C or an organic solid surface having surface tension of 30-70 dyn/cm at 20°C, collecting the solid surface on which the nucleic acid is precipitated, and eluting the nucleic acid.
The solid surface may, optionally, be washed prior to elution of the nucleic acid. The surface tension is a measure of the reversible work required to create a unit surface (interfacial) area at constant temperature, pressure, and composition. The surface tension is also referred to as an interfacial tension.
Although steps of the invention can be carried out at temperatures other than ambient temperature, any of the steps, including the elution step, can be conveniently carried out at ambient temperature. Ambient temperature is generally from about 18 C to about 28°C, and preferably from about 22°C to about 25°C.
The solid surfaces having surface tensions in the ranges described above are polar surfaces which interact with precipitated nucleic acid so that precipitated nucleic acid can stay on the solid surfaces, non specifically associated with the solid surface. Examples of inorganic solid surfaces having surface tension of 38-70 dyn/cm in water at 20°C are borosilicates, aluminosilicates, aluminum oxides, and silicas. For the organic surfaces of the invention, the surface tension range is 30-70 dyn/cm at 20°C. Some examples of organic solid surfaces used in the invention are cellulose acetate, mixed cellulose esters, nylons, nitrocellulose, polyethylidene fluoride, polycarbonates, and polyethersulfone.
The preferred range for organic solid surface is 38-60 dyn/cm at 20°C for purification of DNA. For purification of RNA, the preferred range is 3060 dyn/cm. For example, cellulose acetate has a surface tension of 45.9 dyn/cm, nylon has a surface tension of 46.5 dyn/cm, nitrocellulose has a surface tension of 38 dyn/cm, and glass has a surface tension of 46 dyn/cm. The solid surfaces can be of a material having the desired surface tension, or chemically or physically modified solids to achieve a surface tension in the desired range. A skilled artisan knows how to determine the surface tension of a solid.
The solid surfaces may be in the forms of beads, particles, membranes, or filters. The order of mixing the sample solution, the water miscible organic solvent and the solid support is, generally, not important. For solid surfaces which are in the form of particles and beads, it is necessary that the solid support be well mixed with the sample and organic solvent liquids.
The sample solution may, in general, be used as it is at the end of some previous biological or chemical manipulation, without requiring any pre-treatment. The previous biological manipulation may be, for example, an extraction from a biological tissue or an enzymatic reaction. The sample solution may or may not contain salt. The sample solution may contain a mixture of nucleic acids, nucleotides, enzymes and proteins in general, carbohydrates, lipids, and generally, any component of a prior purification or molecular manipulation of a biological sample. For example, the sample may be a cell lysate or a sequencing reaction. A sequencing reaction buffer may contain 80 mM Tris and 2 mM MgCl2. Any treatment that removes undesirable molecules from the sample solution prior to mixing the sample solution with the organic solvent miscible in water and solid support will not interfere with the purification method of the invention.
The organic solvents useful for the invention are water miscible, i.e. they form one phase when mixed in water. They may be alcohol, amide, ketone, acetonitrile, acetic acid, dimethyl formamide, dioxane, polyethylene glycol and the like. Preferred solvents are alcohol and acetonitrile. Preferred alcohols are ethanol, isopropanol, n-propanol, and butanol.
Starting concentration of the water miscible organic solvent may range 50-100%. A single such solvent or a mixture of the above solvents may be used in the invention. When water miscible organic solvent is mixed with the sample solution, one phase is formed. Sufficient organic solvent is added so the nucleic acid is separated from the solution and precipitated on the solid surface. The solid surface interacts with the precipitated nucleic acid so that the nucleic acid stays on the solid surface. The process can be conducted at ambient temperature.
In general, water miscible organic solvent is added to the aqueous sample solution so that 30-80 % final concentration of the organic solvent is achieved. Preferably, a 50- 75% final concentration is achieved. In general, water miscible organic solvent can be added at ambient temperature. It may be added also at a lower temperature and it may be cooled to below ambient temperature prior to addition. In accordance with the method of the invention, a sample solution is mixed with water miscible organic solvent and solid surfaces. The mixing may be by any mechanical action such as pipetting, inverting, or vortexing, etc. The solid surface with precipitated nucleic acid may be separated by decanting, filtration, centrifugation, vacuuming and the like. The optional wash step is carried out by addition of a water wash solution to the solid surfaces and then removal of the wash solution by decanting, filtration, centrifugation, vacuuming and the like.
The elution step comprises the addition of primarily salt free liquid and collection of the liquid. Water or a solution with a low ionic strength may be used. The elution step is preferably carried out at ambient temperature, in an elution solution which is at ambient temperature.
Wash step(s) may be included as desired. One or more wash steps may be carried out using the same or different wash solutions. Wash solution compήses a water miscible organic solvent diluted in water. Typically, the wash solution contains 0 - 70% water and 30 - 100 % water miscible organic solvent. The organic solvent may be the same as the miscible organic solvent initially mixed with the nucleic acid containing aqueous sample solution or it may be a different organic solvent. More than one water miscible organic solvents may be used as desired, in any one washing step or in subsequent washing steps. The wash solution is placed in contact with precipitated nucleic acid and removed by mechanical manipulation such as decantation, centrifugation, filtration, vacuuming, application of positive pressure, and the like.
To achieve the desired wash effect, the wash solutions may further comprise chelating agents, salts, acids or buffers. Examples of chelating agents, but not limited to those examples, are EDTA, DCTA, and citrate. One or more than chelating agents may be used. The chelating agent may be used alone and in combination with other chelating agents. Examples of salt which can be included in the wash solution, but not limited to those examples are sodium chloride, or potassium acetate. One or more than one salt may be used. It can be used alone or with combination of others. An example of an acid which can be included in the wash solution, but not limited to this example is acetic acid. Examples of buffers, but not limited to those examples are Tris, Tris-acetate, sodium phosphate buffer, sodium citrate, sodium acetate and the like. One or more than one buffer may be used. It may be used alone or with combination of others. Examples of wash solutions are solutions containing 0.1 M NaCl alone; 10 mM Tris alone; 1 mM EDTA alone, or a combination thereof, such as, for example, ImM Tris and 1 mM EDTA; 1 mM Tris and 1 mM MgCl2; 1 mM EDTA and 10 mM KC1; lOmM sodium phosphate and 0.2 mM EDTA and 10 mM KC1. One or more than one wash steps may be performed. More than one wash solutions used may be same or may be different in each wash step. The wash steps can be carried out at ambient temperature.
The eluting solution is primarily salt free liquid. Preferred eluting solution is water. A low ionic strength may be used if desired. Low ionic strength solution may be, in general, any liquid that has a conductivity less than lmS/cm. The ionic strength of a solution is measured as conductivity of the solution. The conductivity can be conveniently measured by use of a Digital Conductivity Meter (Fisher Scientific). An artisan skilled in the art knows how to measure conductivity of solutions. Eluting solutions are preferably used at ambient temperature. An example of a low conductivity elution solution in accordance with the invention, but not limited to this example, would be 10 mM Tris and 1 mM EDTA which has about a 0.7 mS conductivity.
In a preferred embodiment, the solid surface is a filter or a membrane. These filters and membranes are porous solid which have average pore size range 0.1 - 5 μm. Preferred pore sizes range is 0.22 - 2 μm. In this embodiment, the sample solution containing nucleic acid is preferably mixed with water miscible organic solution first, and then the mixture is added to the filter or membrane. The sample solution and organic solvent solution need to be mixed well, not simply adding them together. The nucleic acids stay on the filter through non-specific interaction. The mixed nucleic acid and organic solution is passed through the filter or membrane by centrifugation, vacuuming, applying positive pressure (for example, syringe filtration) or gravity. A wash step may be included. The wash step comprises addition of a wash solution through the filter.
The eluting step generally includes removal of nucleic acid from the filter. The elution liquid is water or a low salt concentration buffer. It is added to the filter and passed through the filter or membrane into a clean collection vessel, or the membrane or filter are rinsed in the elution liquid and the elution liquid which contains the nucleic acid is collected. This whole process is preferably carried out at ambient temperature.
The nucleic acid in the sample which is purified in accordance to the invention is any molecule made of either deoxyribonucleotide or ribonucleotide monomers. Increased organic solvent concentrations will allow recovery of even very short (2 mer) oligonucleotides. Examples of nucleic acids which can be purified by the invention include DNA, DNA fragments, double strands DNA, single strand DNA, RNA, DNA or RNA fragments from amplification reactions and restrictions, oligonucleotides, modified RNA or DNA, or any of the above molecules comprising a modified or labeled nucleotide, or having a label attached thereto, such as a biotin tagged oligonucleotide, fluorescence-tagged DNA, a oligonucleotide or ribonucleotide conjugated with other molecules.
The sample solution is, or can be derived from, any artificial or biological source. For example, the sample can be from a chemical reaction creating synthetic oligonucleotides, a cell culture, a biological tissue, blood, serum, a fermentation broth, plasma, milk, or a body fluid. The sample can be used either directly or following a treatment before use. Examples of pretreatments include disrupting cells and removing cell debris, preparing plasma from, preparing liquid from solid materials, concentrating and diluting the fluids, modifying through chemical or enzyme reactions and the like. An artisan skilled in the art will understand that a sample solution can, therefore, contain a limited amount of organic solvents, typically no more than 10%. Such a solution continues to be the aqueous solution from which nucleic acids are to be purified, in accordance with the invention. The purification of the nucleic acid can be followed by methods well known in the art such as, for example, a UN spectrometer, gel electrophoresis, or radiation detection if the nucleic acid is labeled with isotopes.
The following are examples illustrating the present invention and are intended to be illustrative and not intended to limit the invention. Examples
Example 1 Purification of fluorescent oligonucleotide
To 30 μl PCR buffer containing 0.5 μg 16-mer fluorescent oligonucleotide, 70μl ethanol were added and mixed. Seven equivalent samples were prepared and transferred, one sample each of :
1. glass fiber filter membrane
2. cellulose acetate filter membrane
3. nylon filter membrane
4. aluminum oxide filter membrane
5. polypropylene filter membrane
6. polyvinylidene fluoride filter membrane
7. nitrocellulose filter membrane
A brief centrifugation to remove the liquid followed. We observed that supernatants from filters 1, 2, 3 and 4 have no fluorescence and supernatants from filters 5, 6 and 7 are fluorescent and their strengths are close to original solution. The bound fluorescent oligonucleotide was seen with naked eyes on filters 1, 2, 3 and 4. The oligonucleotides were eluted with 20 μl water run on 1.2 % agarose gel and visualized by staining with ethidium bromide. Unpurified 16-mer oligonucleotide was used as a control. The gel image showed that filters 1, 2, 3 and 4 gave almost 100% yield. However, there are almost no oligonucleotide recovered from filters 5 and 6 and a very low recovery rate was obtained from nitrocellulose membrane. Example 2 Purification of Mspl digested pBR322 DNA
40 μl ethanol was added to 20 μl restriction buffer containing 0.5 μg Mspl digested pBR322 DNA. Six such samples were preferred and transferred to different filter membranes:
1. glass fiber filter membrane
2. cellulose acetate filter membrane
3. nylon filter membrane
4. aluminum oxide filter membrane
5. polypropylene filter membrane
6. polyvinylidiene fluoride filter membrane.
The filters were centrifuged for one minute at 700 xg and washed once with 70% ethanol. The DNA was eluted with 20 μl water. The samples were run on 1.0 % agarose gel and the DNA was visualized by staining with ethidium bromide. Unpurified Mspl digested pBR322 DNA was used as a control. The gel image shows all the DNA bands were recovered with almost 100% yield on filters 1, 2, 3 and 4. However, almost no DNA was recovered from filters 5 and 6.
Example 3 Purification ofλ-DNA
30 μl ethanol was added to 20 μl restriction buffer containing 0.5 μg λ-DNA. Two such samples were prepared, mixed and transferred to different filter membranes:
1. glass fiber filter membrane
2. cellulose acetate filter membrane The filters were centrifuged one minute at 700 xg, washed once with a 70% ethanol containing 1 mM EDTA solution and once with a 70% ethanol solution. Eluted with 20 μl water. The samples were run on 1.0 % agarose gel and the DNA was visualized by staining with ethidium bromide. Unpurified λ-DNA was used as a control. The gel image shows that filters 1 and 2 give almost 100% yield.
Example 4 Purification of DNA from a sequencing reaction
Standard sequencing reaction were performed using a PE Biosystems: The ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction Kit. PGEM-3Zf (+) double stranded template and —21 Ml 3 primer (forward) were used for the sequencing reaction. 10 μl of water and 45 μl of isopropanol or ethanol were added to the reaction solution and mixed. The mix was transferred to glass fiber filters and to cellulose acetate membranes. Vacuum was applied to remove supernatants. The solid support was washed twice with 55% isopropanol. The DNA was eluted with 20μl of water. The samples were then sequenced on an ABI 3700 sequencer. The graphs showed strong DNA signals and removal of terminator dye.
Example 5 Another protocol for purification of DNA from a sequencing reaction
Standard sequencing reactions were performed using a PE Biosystems: The ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction Kit. PGEM-3Zf (+) double stranded template and -21 Ml 3 primer (forward) were used for the sequencing reaction. 10 μl of water and 50 μl of 95% ethanol were added to the reaction solution and mixed. The mix was transferred to glass fiber filters and to cellulose acetate membranes. Vacuum was applied to remove supernatants. The solid support was washed once with 70% ethanol containing 0.5mM EDTA and once with 70% ethanol. The DNA was eluted with 20μl of water. The samples were then sequenced on an ABI 3700 sequencer. The graphs showed strong DNA signals and removal of dye terminator.
Example 6. Purification ofplasmidDNAfrom a cell culture
2 ml DH5α (host E. Coli) with PUC19 vector (from Life Technologies Inc.) were cultured overnight in LB (Lucia Broth) and centrifuged at 14,000 xg for 30 seconds to remove supernatant. The cells were resuspended in 60 μl of 1 x TE (Tris-EDTA buffer). 30 μl of lysis buffer containing 0.25 M NaOH and 1% SDS was added and mixed in by gently inverting until the cells were completely lysed (5-10 minutes). 20 μl of 3M potassium acetate (pH 4) was then added. The resulting mix was centrifuged at 14,000 x g to precipitate the pellet. 150 μl isopropanol was added and mixed well. The solution was transferred to a filter cartridge with glass fiber and centrifuged to remove the supernatant. The solid support was washed twice with a solution containing 50% isopropanol, 10 mMTris, and ImMEDTA. The DNA was eluted with 50 μl water. 10 μl samples were run on a 1 % agarose gel, which indicated a good recovery rate.

Claims

I claim:
1. A method of purification of a nucleic acid from a solution comprising: mixing an aqueous sample solution comprising a nucleic acid, an organic solvent miscible in water, and a solid surface selected from the group consisting of an inorganic solid surface having a surface tension of 38-70 dyn/cm measured in water at 20°C and an organic solid surface having a surface tension of 30-70 dyn cm measured at 20°C; collecting the solid surface on which the nucleic acid is precipitated; and eluting the nucleic acid from the solid surface at ambient temperature.
2. The method of claim 1, wherein the solid surface is an inorganic solid surface having a surface tension of 38-70 dyn/cm in water at 20°C.
3. The method of claim 1, wherein the solid surface is an organic solid surface having a surface tension of 30-70 dyn/cm at 20°C.
4. The method of claim 1, wherein the solid surface is borosilicate, cellulose acetate, nylon, or aluminum oxide.
5. The method of claim 4, wherein the solid surface is borosilicate or cellulose acetate.
6. The method of claim 3, wherein the surface tension is between 33-60 dyn/cm measured at 20°C and the eluted nucleic acid is RNA.
7. The method of claim 3, wherein the surface tension is between 38-60 dyn/cm measured at 20°C and the eluted nucleic acid is DNA.
8. The method of claim 1 , wherein the organic solvent is an alcohol.
9. The method of claim 8, wherein the alcohol is ethanol, isopropanol, n- propanol, or butanol.
10. The method of claim 1 comprising a further step of washing the solid support with a wash solution comprising an organic solvent miscible in water, prior to eluting the nucleic acid.
11. The method of claim 1 or 10, wherein any step of the method is carried out at ambient temperature.
12. The method of claim 1, wherein said nucleic acid is single stranded, double stranded, RNA, DNA, RNA-DNA hybrids, a modified nucleic acid, a tagged nucleic acid, or an oligonucleotide.
13. The method of claim 1 , wherein the elution is in an aqueous liquid having a conductivity of up to ImS/cm.
14. The method of claim 13, wherein said aqueous liquid is water.
15. A kit for purification of a nucleic acid comprising: a container of washing solution comprising 30%-70% organic solvent miscible in water, and a solid surface selected from the group consisting of an inorganic solid surface having a surface tension of 38-70 dyn cm in water at 20°C and an organic solid surface having a surface tension of 30-70 dyn/cm at 20°C, wherein the kit components are used in a method for purification of nucleic acids wherein the nucleic acid is first precipitated onto the solid surface and then eluted from the solid surface at ambient temperature in an aqueous liquid having a conductivity of up to 1 mS/cm2.
16. A kit in accordance with claim 15, wherein said solid surface is an ic solid surface having a surface tension of 38-70 dyn/cm in water at 20°C.
17. The kit of claim 15, wherein said solid surface is an organic solid surface a surface tension of 30-70 dyn/cm at 20°C.
18. The kit of claim 15, wherein the solid surface is borosilicate or cellulose acetate.
19. The kit of claim 17, wherein the surface tension is between 33-60 dyn/cm at 20°C and the eluted nucleic acid is RNA.
20. The kit of claim 17, wherein the surface tension is between 38-60 dyn/cm at 20°C and the eluted nucleic acid is DNA.
PCT/US2001/005575 2000-02-23 2001-02-22 Rapid nucleic acid separation, isolation and purification methods WO2001062976A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001238616A AU2001238616A1 (en) 2000-02-23 2001-02-22 Rapid nucleic acid separation, isolation and purification methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18432800P 2000-02-23 2000-02-23
US60/184,328 2000-02-23

Publications (1)

Publication Number Publication Date
WO2001062976A1 true WO2001062976A1 (en) 2001-08-30

Family

ID=22676444

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/005575 WO2001062976A1 (en) 2000-02-23 2001-02-22 Rapid nucleic acid separation, isolation and purification methods

Country Status (2)

Country Link
AU (1) AU2001238616A1 (en)
WO (1) WO2001062976A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003040687A2 (en) 2001-11-06 2003-05-15 Cortex Biochem, Inc. Isolation and purification of nucleic acids
EP1382677A1 (en) * 2002-07-19 2004-01-21 Fuji Photo Film Co., Ltd. A method for separating and purifying a nucleic acid
WO2004094672A1 (en) * 2003-04-17 2004-11-04 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures
EP1599489A1 (en) * 2002-02-13 2005-11-30 Medimolecular Pty. Ltd. Method of isolating nucleic acids from stool samples
US7347976B2 (en) 2001-12-20 2008-03-25 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix
US7682818B2 (en) 2003-03-28 2010-03-23 Fujifilm Corporation Apparatus for separating and purifying nucleic acid and method for separating and purifying nucleic acid
US7871827B2 (en) 2001-12-20 2011-01-18 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using anion exchange
US7939249B2 (en) 2003-12-24 2011-05-10 3M Innovative Properties Company Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
WO2015157650A1 (en) * 2014-04-11 2015-10-15 Wako Pure Chemical Industries, Ltd Nucleic acid purification method
DE102014214173A1 (en) 2014-07-21 2016-01-21 Aj Innuscreen Gmbh A method for the selective size fractionated isolation of nucleic acids
DE102015222002A1 (en) 2014-11-07 2016-05-12 Aj Innuscreen Gmbh A method for the selective size fractionated separation and isolation of nucleic acid mixtures
WO2016169677A1 (en) * 2015-04-23 2016-10-27 Aj Innuscreen Gmbh Method and test kit for rapid isolation of nucleic acids using rough surfaces

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990301A (en) * 1994-02-07 1999-11-23 Qiagen Gmbh Process for the separation and purification of nucleic acids from biological sources
US6037465A (en) * 1994-06-14 2000-03-14 Invitek Gmbh Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials
US6084091A (en) * 1995-08-16 2000-07-04 Max-Planck-Gesellschaft Zur Forerung Der Wissenschaften E.V. Process for purifying, stabilising or isolating nucleic acids from biological materials

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990301A (en) * 1994-02-07 1999-11-23 Qiagen Gmbh Process for the separation and purification of nucleic acids from biological sources
US6037465A (en) * 1994-06-14 2000-03-14 Invitek Gmbh Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials
US6084091A (en) * 1995-08-16 2000-07-04 Max-Planck-Gesellschaft Zur Forerung Der Wissenschaften E.V. Process for purifying, stabilising or isolating nucleic acids from biological materials

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264927B2 (en) 2001-11-06 2007-09-04 Cortex Biochem, Inc. Isolation and purification of nucleic acids
WO2003040687A2 (en) 2001-11-06 2003-05-15 Cortex Biochem, Inc. Isolation and purification of nucleic acids
EP1442045A2 (en) * 2001-11-06 2004-08-04 Cortex Biochem Inc. Isolation and purification of nucleic acids
EP2258845A3 (en) * 2001-11-06 2012-03-21 Promega Corporation Isolation and purification of nucleic acids
EP2000533A3 (en) * 2001-11-06 2009-07-08 Promega Corporation Isolation and purification of nucleic acids
EP1442045A4 (en) * 2001-11-06 2006-09-27 Cortex Biochem Inc Isolation and purification of nucleic acids
AU2002333673B2 (en) * 2001-11-06 2008-08-14 Promega Corporation Isolation and purification of nucleic acids
US7347976B2 (en) 2001-12-20 2008-03-25 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using a hydrophilic solid support in a hydrophobic matrix
US7871827B2 (en) 2001-12-20 2011-01-18 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using anion exchange
EP1599489A4 (en) * 2002-02-13 2007-01-03 Medimolecular Pty Ltd Method of isolating nucleic acids from stool samples
EP1599489A1 (en) * 2002-02-13 2005-11-30 Medimolecular Pty. Ltd. Method of isolating nucleic acids from stool samples
US7252939B2 (en) 2002-07-19 2007-08-07 Fujifilm Corporation Method for separating and purifying a nucleic acid
EP1382677A1 (en) * 2002-07-19 2004-01-21 Fuji Photo Film Co., Ltd. A method for separating and purifying a nucleic acid
US7682818B2 (en) 2003-03-28 2010-03-23 Fujifilm Corporation Apparatus for separating and purifying nucleic acid and method for separating and purifying nucleic acid
US7981600B2 (en) 2003-04-17 2011-07-19 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures using an anion exchange material that includes a polyoxyalkylene
WO2004094672A1 (en) * 2003-04-17 2004-11-04 3M Innovative Properties Company Methods and devices for removal of organic molecules from biological mixtures
US7939249B2 (en) 2003-12-24 2011-05-10 3M Innovative Properties Company Methods for nucleic acid isolation and kits using a microfluidic device and concentration step
WO2015157650A1 (en) * 2014-04-11 2015-10-15 Wako Pure Chemical Industries, Ltd Nucleic acid purification method
DE102014214173A1 (en) 2014-07-21 2016-01-21 Aj Innuscreen Gmbh A method for the selective size fractionated isolation of nucleic acids
DE102015222002A1 (en) 2014-11-07 2016-05-12 Aj Innuscreen Gmbh A method for the selective size fractionated separation and isolation of nucleic acid mixtures
WO2016071535A1 (en) 2014-11-07 2016-05-12 Aj Innuscreen Gmbh Method for the selective size-fractionated separation and isolation of nucleic acid mixtures
WO2016169677A1 (en) * 2015-04-23 2016-10-27 Aj Innuscreen Gmbh Method and test kit for rapid isolation of nucleic acids using rough surfaces
JP2018520696A (en) * 2015-04-23 2018-08-02 エイ・ジェイ イヌスクリーン ゲゼルシャフト ミット ベシュレンクテル ハフツングAJ Innuscreen GmbH Method and test kit for rapid isolation of nucleic acids with rough surfaces
US10934540B2 (en) 2015-04-23 2021-03-02 Aj Innuscreen Gmbh Method and test kit for rapid isolation of nucleic acids using rough surfaces

Also Published As

Publication number Publication date
AU2001238616A1 (en) 2001-09-03

Similar Documents

Publication Publication Date Title
EP0988307B1 (en) Solid-phase nucleic acid isolation
US8691969B2 (en) Isolation of nucleic acid
US5596092A (en) Extraction of genomic DNA from blood using cationic detergents
CN109072234B (en) Protein-based sample collection matrices and devices
US20140094597A1 (en) Method for isolating nucleic acids comprising the use of ethylene glycol multimers
US20070031880A1 (en) Chemical treatment of biological samples for nucleic acid extraction and kits therefor
US7893228B2 (en) Compositions and methods for using a solid support to purify RNA
JP2002502856A (en) Methods for isolating and purifying nucleic acids
US20200255820A1 (en) Process for concentrating cells from a sample and then isolating nucleic acids from said cells
WO2001062976A1 (en) Rapid nucleic acid separation, isolation and purification methods
EP4163371A1 (en) Nucleic acid extraction method and application
Thatcher Nucleic acid isolation
US7364857B2 (en) Method of purifying nucleic acid using silver nanoparticles
ES2350291T3 (en) METHOD FOR ISOLATING NUCLEIC ACIDS THAT INCLUDES THE USE OF ETHYLENE GLYCOL MULTIMERS.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP